M C C M Hulshof
Overview
Explore the profile of M C C M Hulshof including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
2696
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schuring N, Stam W, Plat V, Kalff M, Hulshof M, van Laarhoven H, et al.
Eur J Surg Oncol
. 2023 Jun;
49(10):106947.
PMID: 37355392
Background: Recurrence is frequently observed after esophageal cancer surgery, with dismal post-recurrence survival. Neoadjuvant chemoradiotherapy followed by esophagectomy is the gold standard for resectable esophageal tumors in the Netherlands. This...
2.
Vernooij R, Cremers R, Jansen H, Somford D, Kiemeney L, van Andel G, et al.
Urol Oncol
. 2022 Jun;
40(7):353.
PMID: 35654644
No abstract available.
3.
Creemers A, van der Zalm A, van de Stolpe A, Holtzer L, Stoffels M, Hooijer G, et al.
J Transl Med
. 2022 Apr;
20(1):183.
PMID: 35468793
In this study we aimed to investigate signaling pathways that drive therapy resistance in esophageal adenocarcinoma (EAC). Paraffin-embedded material was analyzed in two patient cohorts: (i) 236 EAC patients with...
4.
Jezerskyte E, van Berge Henegouwen M, van Laarhoven H, van Kleef J, Eshuis W, Heisterkamp J, et al.
Ann Surg Oncol
. 2021 May;
28(12):7259-7276.
PMID: 34036429
Background: Esophagectomy has major effects on health-related quality of life (HR-QoL). Postoperative complications might contribute to a decreased HR-QOL. This population-based study aimed to investigate the difference in HR-QoL between...
5.
Jezerskyte E, Saadeh L, Hagens E, Sprangers M, Noteboom L, van Laarhoven H, et al.
J Gastrointest Surg
. 2020 Sep;
25(7):1657-1666.
PMID: 32909195
Background: The impact of transthoracic (TTE) and transhiatal esophagectomy (THE) on long-term health-related quality of life (HR-QoL) in patients with distal esophageal or gastro-esophageal junction (GEJ) cancer has been studied...
6.
Vernooij R, Cremers R, Jansen H, Somford D, Kiemeney L, van Andel G, et al.
Urol Oncol
. 2020 Jul;
38(9):735.e17-735.e25.
PMID: 32680820
Background: Although urinary adverse events after treatment of prostate cancer (CaP) are common, population-based studies on functional outcomes are scarce. The aim of this study is to evaluate the occurrence...
7.
Jezerskyte E, Saadeh L, Hagens E, Sprangers M, Noteboom L, van Laarhoven H, et al.
Dis Esophagus
. 2020 May;
33(11).
PMID: 32444879
Introduction: Both cervical (McKeown) and intrathoracic (Ivor Lewis) anastomosis of transthoracic esophagectomy are surgical procedures that can be performed for distal esophageal or gastro-esophageal junction (GEJ) cancer. The purpose of...
8.
Mulder F, Hovenkamp A, van Laarhoven H, Buller H, Kamphuisen P, Hulshof M, et al.
Br J Surg
. 2020 May;
107(10):1324-1333.
PMID: 32424862
Background: In patients who undergo curative treatment for oesophageal cancer, risk estimates of venous thromboembolism (VTE), arterial thromboembolism and bleeding are needed to guide decisions about thromboprophylaxis. Methods: This was...
9.
Hagens E, Feenstra M, Eshuis W, Hulshof M, van Laarhoven H, van Berge Henegouwen M, et al.
Br J Surg
. 2020 Feb;
107(8):1053-1061.
PMID: 32017047
Background: Conditional survival accounts for the time already survived after surgery and may be of additional informative value. The aim was to assess conditional survival in patients with oesophageal cancer...
10.
Schooneveldt G, Kok H, Bakker A, Geijsen E, Hulshof M, de Reijke T, et al.
Int J Hyperthermia
. 2018 Oct;
35(1):441-449.
PMID: 30303415
Purpose: Loco-regional hyperthermia combined with mitomycin C is used for treatment of nonmuscle invasive bladder cancer (NMIBC). Air pockets may be present in the bladder during treatment. The aim of...